SCIENTIFIC EXPERTISE IN ONCOLOGY AND BONE DISEASES
Over 20 years of experience in leading biomedical research and business.

March 2, 2021

Agency Agreement with Gucon

OncoBone has entered into an agency agreement with Guangdong Gucon Biotech Co. Ltd (“Gucon”). The agreement is exclusive, including Gucon to help OncoBone in finding new business in China.

Jussi Halleen, CEO of OncoBone comments: “I have known Gucon for more than 10 years and I am convinced that through their expertise and large network of potential customers of OncoBone, Gucon will be able to contribute extensively in expanding our business in China.”

Simon Guo, General Manager of Gucon adds: “Gucon is excited to work with OncoBone and has strong expectations for the collaboration. Gucon expects that especially the strong scientific expertise of OncoBone in oncology and bone biology will be attractive to our network

February 25, 2021

Co-operation with PharmaLegacy

OncoBone is pleased to announce co-operation with the Shanghai-based preclinical CRO PharmaLegacy. In the co-operation OncoBone will provide its expertise to support PharmaLegacy in expanding its client-base especially in Europe.

Jussi Halleen, CEO of OncoBone says: “I know PharmaLegacy from 10 years back when I visited them in Shanghai. I was impressed then and am even more impressed today about their continuing success in preclinical CRO business. I am convinced that OncoBone is in an excellent position to help PharmaLegacy expanding their business further, especially in our key expertise fields oncology and bone diseases.

Michael Zhang, VP of PharmaLegacy adds: “We are very impressed about the high reputation of OncoBone representatives in the fields of oncology and bone diseases. PharmaLegacy has high expectations for OncoBone for successful promotion of especially our oncology and non-human primate models in European markets.

February 19, 2021

OncoBone joins Biocom

OncoBone is proud to announce joining Biocom as a member company. Biocom is the largest and most experienced life science association in California.

On February 23 – 25, 2021, OncoBone will attend Biocom Global Life Science Partnering Conference, an annual bio-pharma partnering conference that brings together leading deal makers and emerging biotechs from around the world.

On March 30, OncoBone will arrange a Biocom webinar “Working with CROs – From selection to managing relationships”, where Dr. Tiina Kähkönen, CSO of OncoBone will speak about “How to choose the right CRO”.

January 20, 2021

Co-operation with MediSapiens

OncoBone and MediSapiens are pleased to announce their cooperation in promoting the newly released MediSapiens Genomics Software Suite (GSS).

GSS is a high-performance, cloud-based genomics back-end solution enabling genomic and clinical data integration and analytics. OncoBone will provide its expertise and extensive life science industry network to support MediSapiens in expanding its client-base for GSS.

Jussi Halleen, CEO of OncoBone comments: “The Genomics Software Suite has great potential for global success and we are delighted to have this opportunity to work with MediSapiens in this exciting project.

Nils Effertz, CEO of MediSapiens adds: “We are pleased that OncoBone will be part of a successful launch of our Genomics Software Suite, helping us to work with more partners around the world and expanding the ever-growing value propositions of biomedical data analysis software solutions.

December 2, 2020

OncoBone CSO completes Medical Writing Professional certificate program

OncoBone CSO Tiina Kähkönen has completed a medical writing certificate program and is now recognized as a Certified Medical Writing Professional (CMWP). The program was organized by the Center for Professional Innovation and Education (CfPIE). The courses in the program included technical writing for versioned and regulatory documents for pharmaceutical and biotech industry and medical devices.

September 23, 2020

OncoBone joins Finnish Bioindustries

OncoBone is proud to join Finnish Bioindustries (FIB) as a member company. By joining FIB OncoBone aims to network with Finnish life science companies and explore potential ways to promote Finnish excellence in life sciences to foreign markets.

September 1, 2020

OncoBone launched new webpages

OncoBone has launched new webpages to better visualize our concept and provide easier access to our services for our clients. With the new webpages we would like to welcome anyone interested in life science partnering to get in contact with us.

It has been a pleasure for OncoBone to work with Netello Systems in designing our new modern webpages. OncoBone would like to thank Netello for understanding the concept, excellent communication, and for the great execution of the work.

OncoBone

AT YOUR SERVICE

If you are interested to learn more,
see our services or contact us directly.

    Scientist.com logo Science Exchange logo

    Copyright © 2021 OncoBone Ltd